Our finding of elevated PDL1 on CCR2+CD206+ macrophages that developed in a GM-CSF-dependent manner contributes to an explanation of why neutralizing GM-CSF may lead to impairment of regulatory capacity in IBD. The gene discussed is CCR2; the disease is inflammatory bowel disease.